Restless legs syndrome: a new practice guideline Evidence shows strong support for prescribing pramipexole, rotigotine, cabergoline, or gabapentin enacarbil to treat adults with restless legs syndrome ...
August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.
Guangzhou Henovcom Bioscience Co. Ltd. has synthesized prodrugs of rotigotine reported to be useful for the treatment of restless legs syndrome, depression and Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results